Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Insulin Resistance 1Hyperandrogenism 1Glucose Intolerance 1Endometrial Neoplasms 1Anovulation 1

Interventions

Metformin 4Inositol 3drospirenone and ethinyl estradiol combination 2Progesterone 2Folic Acid 2Ethinyl Estradiol 2Cyproterone Acetate 2salicylsalicylic acid 1maltodextrin 1licogliflozin 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Time 1Thioctic Acid 1Sugars 1Spironolactone 1Sodium Salicylate 1Phlebotomy 1Lactalbumin 1Inulin 1Insulin 1Glycoprotein Hormones, alpha Subunit 1Flutamide 1Estrogens 1Estradiol 1Doxycycline 1Clomiphene 1Cardiovascular Physiological Phenomena 1Body Mass Index 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperandrogenism × Inulin × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡